In a recent announcement, it has been revealed that Medicare and Medicaid will now cover certain prescriptions for weight-loss drugs, such as Wegovy. This marks a significant shift in coverage policies that could potentially benefit many patients struggling with obesity.
One of the key highlights of this new coverage is that Wegovy is now covered by Medicare for patients at risk of heart disease. This is a major development as obesity is a known risk factor for heart disease, and losing weight can significantly reduce this risk.
Dr. Disha Narang, a leading expert at Endeavor Health in Illinois, has been vocal in discussing the benefits of weight-loss drugs like Wegovy. She emphasizes that these medications can be a valuable tool for patients struggling to lose weight, especially those at risk of heart disease.
With this change in coverage, many patients at risk of heart disease could now have access to weight-loss drugs like Wegovy, which could help them achieve their weight-loss goals and ultimately improve their overall health.
This news is especially significant for the many Americans who struggle with obesity and its related health issues. By expanding coverage for weight-loss drugs, Medicare and Medicaid are taking a step towards addressing the obesity epidemic and potentially improving the lives of countless individuals.
“Prone to fits of apathy. Devoted music geek. Troublemaker. Typical analyst. Alcohol practitioner. Food junkie. Passionate tv fan. Web expert.”